WAVEMAN · COMPANY

MG · Mistras Group, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

MG

Name: Mistras Group, Inc. (MG) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Mistras Group, Inc.

PHARMA & BIOTECH · SERVICES-ENGINEERING SERVICES · CIK 0001436126

ACTIVIST 13D☆ WATCH

INSIDER NET · 180D

-$18.0K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-0.8%

XBRL, annual

NET MARGIN

2.3%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$18.0K over 180 days

-$18.0K of it by a 10%+ holder

more than 61% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

86 funds added or opened last quarter

more than 60% of Pharma & Biotech

REVENUE

-0.8% year over year

below 58% of Pharma & Biotech

MARGIN

2.3% net margin

more than 70% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

3.8% of shares outstanding short · 7.8 days to cover · settled 2026-07-31

below 53% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

86 funds added or opened positions in the latest 13F quarter, of 140 holders.

Stephanie Foglia disclosed a 5%+ stake (21.72%) in the last six months.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +99.4%

+99.4%12M

INSIDER BUYINSIDER SELL13D/G STAKE

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

An activist crossed the 5% line with declared intent.

The record shows a net $18.0K sold by insiders over 180 days, 86 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Mistras Group, Inc. insiders sold a net $18.0K of stock across 30 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Foglia Stephanie Athena

—

SELL

2026-04-17

1,000.0

$18.0K

Foglia Stephanie Athena

—

SELL

2026-03-03

1,000.0

$15.5K

Foglia Stephanie Athena

—

SELL

2026-02-03

1,000.0

$14.6K

Foglia Stephanie Athena

—

SELL

2026-01-05

1,000.0

$13.6K

Coggins Eileen Mary

EVP & Chief Legal Officer

BUY

2025-09-15

15,000.0

$143.2K

30 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 25 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Mill Road Capital Management LLC

1,929,509.0 sh

$33.7M

DIMENSIONAL FUND ADVISORS LP

1,700,793.0 sh

$29.7M

ROYCE & ASSOCIATES LP

1,580,728.0 sh

$27.6M

WEBER CAPITAL MANAGEMENT LLC /ADV

1,448,154.0 sh

$25.3M

BlackRock, Inc.

1,166,197.0 sh

$20.4M

5%+ owners

13D = intent to influence · 13G = passive

Stephanie Foglia

ACTIVIST 13D · 2026-03-31

21.72%

2025 Irrevocable Two-Year Grantor Retained Annuity Trust of Aspasia F. Vahaviolos

ACTIVIST 13D · 2026-03-31

16.62%

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

The Adirondack Small Cap Fund

$800.1K POSITION · AS OF 2026-03-31

1.6%

Knights of Columbus Small Cap Equity Fund

$2.4M POSITION · AS OF 2026-04-30

1.2%

Inspire Fidelis Multi Factor ETF

$1.9M POSITION · AS OF 2026-02-28

1.1%

1290 Essex Small Cap Growth Fund

$1.2M POSITION · AS OF 2026-04-30

1.1%

Royce Small-Cap Opportunity Fund

$9.4M POSITION · AS OF 2026-03-31

0.8%

DWS Small Cap Core Fund

$5.5M POSITION · AS OF 2026-03-31

0.5%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$724.0M	$729.6M	$705.5M	$687.4M
GROSS PROFIT	$204.5M	$192.2M	$184.3M	$198.2M
OPERATING INCOME	$40.6M	$39.8M	$-1.9M	$19.8M
NET INCOME	$16.8M	$19.0M	$-17.5M	$6.5M
EPS (DILUTED)	0.53	0.60	-0.58	0.21
OPERATING CASH FLOW	$33.0M	$50.1M	$26.7M	$26.4M
CASH	$28.0M	$18.3M	$17.6M	$20.5M
LONG-TERM DEBT	$165.1M	$158.1M	$181.5M	$183.8M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE